Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Leukemia 1 Glioblastoma 1 Epstein-Barr Virus Infections 1 Cytomegalovirus Infections 1 Brain Neoplasms 1 Adenocarcinoma 1

Interventions

Temozolomide 45 Radiotherapy 17 Magnetic Resonance Spectroscopy 17 Specimen Handling 14 pembrolizumab 12 Bevacizumab 12 Lomustine 9 Radiation 8 fludarabine 7 Cyclophosphamide 7 atezolizumab 4 Biopsy 4 olaparib 3 Transurethral Resection of Bladder 3 Surgical Procedures, Operative 3 Nivolumab 3 Leukapheresis 3 D2C7-(scdsFv)-PE38KDEL 3 Blood Specimen Collection 3 Aminolevulinic Acid 3 regorafenib 2 fluciclovine F-18 2 contrast agent BR1 2 antisecretory factor 2 abemaciclib 2 Restraint, Physical 2 Re-Irradiation 2 Radiation Dose Hypofractionation 2 Palliative Care 2 Oncolytic Virotherapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Glioblastoma × Valacyclovir × Clear all

NCT07346144 2026-05-04

ADePT

Trogenix ltd

Phase 1/2 Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡